CTTI Unveils New Recommendations to Improve Clinical Trials Posted on October 21, 2019June 21, 2021 by Hannah Faulkner CTTI Unveils New Recommendations to Improve Clinical Trials
Engaging Patients in Medicines Regulation: A Tale of Two Agencies Posted on September 30, 2019June 21, 2021 by Hannah Faulkner Engaging Patients in Medicines Regulation: A Tale of Two Agencies
Giving Patients a Sense of Belonging Posted on September 18, 2019July 9, 2021 by Hannah Faulkner Giving Patients a Sense of Belonging
Viewpoint: Stronger Regulations Are Necessary to Weed Out ‘Digital Snake Oil’ From Wearables, Apps Posted on August 22, 2019June 21, 2021 by Hannah Faulkner Viewpoint: Stronger Regulations Are Necessary to Weed Out ‘Digital Snake Oil’ From Wearables, Apps
FDA Affirms Interest in Promoting Decentralized Clinical Trials Posted on August 12, 2019June 21, 2021 by Hannah Faulkner FDA Affirms Interest in Promoting Decentralized Clinical Trials
A ‘Best Practice’: ACRO, Pharma Respond to FDA Draft Guidance as RBM Adoption Increases Posted on May 30, 2019June 21, 2021 by Hannah Faulkner A ‘Best Practice’: ACRO, Pharma Respond to FDA Draft Guidance as RBM Adoption Increases
Q&A: A New Society Targets Digital Medicine Alongside FDA Officials Posted on May 16, 2019July 9, 2021 by Hannah Faulkner Q&A: A New Society Targets Digital Medicine Alongside FDA Officials
DCRI Helps FDA Map Strategy to Broaden Use of Real-World Evidence Posted on April 24, 2019July 9, 2021 by Hannah Faulkner DCRI Helps FDA Map Strategy to Broaden Use of Real-World Evidence
World Health Organization Releases Guidelines for Digital Health Adoption Posted on April 17, 2019July 9, 2021 by Hannah Faulkner World Health Organization Releases Guidelines for Digital Health Adoption
Statement by FDA Commissioner Scott Gottlieb, M.D., on New Strategies to Modernize Clinical Trials to Advance Precision Medicine, Patient Protections and More Efficient Product Development Posted on March 14, 2019July 9, 2021 by Hannah Faulkner Statement by FDA Commissioner Scott Gottlieb, M.D., on New Strategies to Modernize Clinical Trials to Advance Precision mMedicine, Patient Protections and More Efficient Product Development
